MAJOR CARDIOVASCULAR EVENTS Clinical Trials

7 clinical trials for MAJOR CARDIOVASCULAR EVENTS across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MK-0616 IN REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PARTICIPANTS AT HIGH CARDIOVASCULAR RISK — RECRUITING · PHASE3
• A DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTICENTER STUDY TO EVALUATE THE IMPACT OF EVOLOCUMAB ON MAJOR CARDIOVASCULAR EVENTS IN PATIENTS AT HIGH CARDIOVASCULAR RISK WITHOUT PRIOR MYOCARDIAL INFARCTION OR STROKE — RECRUITING
• INFLUENZA VACCINE TO EFFECTIVELY STOP CARDIO THORACIC EVENTS AND DECOMPENSATED HEART FAILURE (INVESTED) — RECRUITING
• PHASE 3 MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF PF-04950615, IN REDUCING THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN HIGH RISK SUBJECTS — RECRUITING · PHASE3
• PHASE 3 MULTI-CENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF PF-04950615, IN REDUCING THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN HIGH RISK SUBJECTS — RECRUITING · PHASE3
• Impact of Triglyceride-Glucose Index on Cardiovascular Outcomes in Patients Presented With MINOCA — NOT_YET_RECRUITING
• COLCHICINE FOR THE PREVENTION OF VASCULAR EVENTS AFTER AN ACUTE INTRACEREBRAL HEMORRHAGE (COVASC-ICH) — COMPLETED

Refine this search